🍄 Trip Sheet: Clearmind (CMND) hires D.C. lobbying team to fast-track psychedelic therapies

Enveric (ENVB) wins USPTO nod for its non-hallucinogenic tryptamine patents, while Cybin (CYBN) gets a bullish $106 price target in new analyst coverage.